Insider Transactions in Q1 2022 at Gossamer Bio, Inc. (GOSS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2022
|
Bryan Giraudo COO/CFO |
SELL
Open market or private sale
|
Direct |
10,722
-9.76%
|
$85,776
$8.91 P/Share
|
|
Mar 23
2022
|
Faheem Hasnain President & CEO |
SELL
Open market or private sale
|
Direct |
19,035
-11.71%
|
$152,280
$8.91 P/Share
|
|
Mar 23
2022
|
Waage Christian EVP, Tech Ops and Admin |
SELL
Open market or private sale
|
Direct |
10,722
-1.82%
|
$85,776
$8.91 P/Share
|
|
Mar 16
2022
|
Richard Aranda Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,278
-2.88%
|
$50,224
$8.28 P/Share
|
|
Mar 16
2022
|
Caryn Peterson EVP, Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
6,279
-8.67%
|
$50,232
$8.28 P/Share
|
|
Mar 16
2022
|
Laura Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,002
-5.25%
|
$40,016
$8.28 P/Share
|